期刊文献+

血管紧张素转换酶抑制剂在冠心病患者中应用中国专家共识 被引量:32

下载PDF
导出
摘要 1制定共识背景近年来,冠心病等心血管疾病成为我国的首位死因,严重威胁人民的健康。《中国心血管病报告2014》显示,我国心脑血管疾病现患人数为2.9亿,其中心肌梗死患者250万,心血管患病率处于持续上升阶段。
出处 《中国循环杂志》 CSCD 北大核心 2016年第5期420-425,共6页 Chinese Circulation Journal
  • 相关文献

参考文献5

二级参考文献89

  • 1谭慧琼,朱俊,梁岩,章晏,刘力生,代表OASIS登记试验中国地区协作组.非ST段抬高的急性冠状动脉综合征二年随访[J].中华医学杂志,2005,85(3):184-188. 被引量:12
  • 2OASIS协作组,梁岩,谭慧琼,朱俊,章晏,刘力生.我国非ST段抬高急性冠状动脉综合征患者猝死或心律失常死亡事件危险因素分析[J].中国危重病急救医学,2005,17(3):142-145. 被引量:10
  • 3<血管紧张素转换酶抑制剂在肾脏病中正确应用>专家协会组.血管紧张素转换酶抑制剂在肾脏病中正确应用的专家共识[J].中华肾脏病杂志,2006,22(1):57-58. 被引量:69
  • 4Piegns LS,Flather M,Pogue J,et al.The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina.Am J Cardiol,1999,84:7M-12M.
  • 5Prabhakaran D,Yusuf S,Mehts S,et al.Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome:results of the OASIS registry 1 and 2.Indian Heart J,2.005,57:217-225.
  • 6Newby LK,Bhapkar MV,White HD,et al.Predictors of 90-day outcome in patients stabilized after acute coronary syndromes.EtaHeart J,2003,24:172-181.
  • 7Anderson JL,Adams CD,Amman EM,et al.ACC/AHA 2007 guidelines for the management of patients with unstable angina/nonST-Elevation myocardial infarction:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-STElevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians,the Society for Cardiovascular Angiegraphy and Interventions,and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.J Am Coll Canliol.2007,50:e1-e157.
  • 8Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology,Bassand JP,Harem CW,et al.Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.Eur Heart J,2007,28:1598-1660.
  • 9Fox KA,Mehts SR,Peters R,et al.Benefits and risks of the combination of elopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome:the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.Circulation,2004,110:1202-1208.
  • 10Cohen M,Mahaffey KW,Pieper K,et al.A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial:enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.J Am Coll Cardiol,2006,48:1346-1354.

共引文献228

同被引文献237

引证文献32

二级引证文献146

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部